Mesothelioma.com Resources for Patients and their Families

Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed

Brief Summary

The purpose of this study is to register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC.

Tracking Information
First Received DateJune 8, 2012
Last Changed DateJuly 28, 2016
Start DateMay 2012
Anticipated Primary Completion DateJune 2018
Primary Outcome Measures

To improve the prognosis/survival of patients with malignancies localized on the peritoneal surface. [Time Frame: Follow-up over a time period of at least 5 years]

Descriptive Information
PhaseN/A
Study TypeObservational
Condition
  • Peritoneal Carcinomatosis
  • Pseudomyxoma Peritonei
  • Peritoneal Mesothelioma
Study Arms / Comparison Groups0 / 1
Detailed Description

To register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC. In this surgical intervention, the abdominal cavity is macroscopically cleared of tumor, by removing all visible tumor nodules, and is subsequently rinsed with hyperthermic (heated) chemotherapy, aiming to destroy all residual invisible tumor cells that might have stayed behind after the debulking.

The eventual aim of this procedure is to improve the prognosis/survival of patients with malignancies localized on the peritoneal surface.

Recruitment Information
Recruitment StatusRecruiting
Anticipated Enrollment125
GenderAll
AgesN/A - N/A
Accepts Healthy VolunteersNo
Contact Isabelle B Terrasson
Email: isabelle.terrasson@uzleuven.be
Phone: +32 16 340837
Eligibility Criteria

Inclusion Criteria:

- Patients with peritoneal carcinomatosis of colorectal origin, patients with pseudomyxoma peritonei (type DPAM or PMCA) and patients with peritoneal mesothelioma who are planned to undergo cytoreductive surgery and HIPEC because of a peritoneal surface malignancy

Administrative Information
NCTIDNCT01617382
Responsible Party,
SponsorUniversitaire Ziekenhuizen Leuven
Verification DateJuly 2016
Mesothelioma Doctors by State
  • Breaking News
  • Emerging Clinical Trials
  • Delivered within 24 hrs

Yes   No

Mesothelioma Cancer Alliance Blog

FEATURED CONTENT:


RECENT POSTS:

Remembering Mesothelioma Victims in the UK

The Challenges of Research in Immunotherapy

The Importance of Cancer Research in Immunotherapy

Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

Have you or someone you know been diagnosed with mesothelioma?

Get Access To: